Isracann Biosciences Inc.
ISCNF · OTC
5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
|---|---|---|---|---|
| Market Cap | $9 | $33 | $42 | $5 |
| - Cash | $0 | $2 | $4 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $9 | $31 | $38 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$5 | -$11 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$25 | -$24 | -$10 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.032 | -0.18 | -0.26 | -0.75 |
| % Growth | 82.3% | 30.8% | 65.3% | – |
| Operating Cash Flow | -$2 | -$4 | -$10 | -$3 |
| Capital Expenditures | $0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$2 | -$4 | -$11 | -$3 |